The problem of infertility has aggravated globally with rise in advanced maternal age and various other factors. ?Global Assisted Reproductive Technology (ART) Market - In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022? provides an in-depth analysis of global Assisted Reproductive Technology (ART) market overall as well as major technologies such as In Vitro Fertilization, Artificial Insemination and Third-Party Assisted ART (Sperm donation, Egg donation, Embryo donation and Surrogates). Market outlook for overall Assisted Reproductive Technology (ART) market as well as aforementioned sub-segments has been provided for the period 2017-22.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global assisted reproductive technology market. The report has been segmented as following:-
Market Segmentation
? In Vitro Fertilization
? Artificial Insemination
? Third-Party Assisted ART

Geographical Coverage
? Global
? Americas
? Asia Pacific
? Europe, Middle East & Africa

Companies Coverage
? Merck & Co., Inc.
? CooperSurgical, Inc.
? Irvine Scientific Sales Company, Inc.
? Vitrolife AB
? Hamilton Thorne, Inc.,

Infertility is a medical condition characterized by inability to achieve pregnancy. The problem has aggravated in many parts of the world underscoring the need for technological prowess to address the issue. Advancement in medical technology has brought forth Assisted Reproductive Technology (ART) which is acting as saviour for treatment of infertility. ART procedures spans from Invitro Fertilization, Artificial Insemination technologies such as Intrauterine Insemination, Intravaginal Insemination and Intracervical Insemination to third party assisted ART. Adoption rate of ART techniques has been increasing at fast pace globally.
Growth of global Assisted Reproductive Technology (ART) market is primarily attributed to factors such as prevalence of infertility, advanced maternal age, high obesity rates, rising level of alcohol and tobacco consumption, low awareness of fertility problems and favourable reimbursement policies. However, the market faces challenges due to stringent regulatory norms and high treatment cost associated with treatment of infertility. The market is characterized by leading trends such growth in strategic alliances and technological advancement in various procedures pertaining to treatment of infertility using ART.
The report ?Global Assisted Reproductive Technology (ART) Market - In Vitro Fertilization, Artificial Insemination and Third Party Assisted ART Market Outlook 2022? provides in-depth analysis of the current scenario, detailed market outlook of the global Assisted Reproductive Technology (ART) market with coverage of major technologies such as In Vitro Fertilization, Artificial Insemination and Third-Party Assisted ART (Sperm donation, Egg donation, Embryo donation and Surrogates). Geographically, the market is segmented into Americas, Asia Pacific and Europe, Middle East & Africa. Future forecasts of ART market overall and across various sub-segments is provided in the report till the year 2022. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global market include Merck & Co., Inc., CooperSurgical, Inc., Irvine Scientific Sales Company, Inc., Vitrolife AB, Hamilton Thorne, Inc., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global assisted reproductive technology market.